https://www.washingtonpost.com/health/2023/11/17/rsv-drug-beyfortus-cdc-additional-doses/
0
0
11/17/23 at 8:57pm
Organization
The Washington Post
Author
Sabrina Malhi
The move is the latest step by federal agencies to address shortages of the therapy as the country heads deeper into respiratory virus season.
Create an account
or login to join the discussion